Overview

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Determine the pharmacokinetic interactions between rapamycin and sunitinib in patients with advanced solid tumors.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Chicago
Collaborator:
Pfizer
Treatments:
Everolimus
Sirolimus
Sunitinib